COVID‐SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults

BACKGROUND/OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection causes high morbidity and mortality in older adults with chronic illnesses. Several trials are currently underway evaluating the antimalarial drug hydroxychloroquine as a potential treatment for acute infec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Geriatr Soc
Autors principals: Ross, Sydney B., Wilson, Marnie Goodwin, Papillon‐Ferland, Louise, Elsayed, Sarah, Wu, Peter E., Battu, Kiran, Porter, Sandra, Rashidi, Babak, Tamblyn, Robyn, Pilote, Louise, Downar, James, Bonnici, Andre, Huang, Allen, Lee, Todd C., McDonald, Emily G.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
COVID‐19‐Related Content
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280600/
https://ncbi.nlm.nih.gov/pubmed/32441771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.16623
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars